Combination immunotherapy in a patient with hemodialysis therapy and metachronous bilateral clear cell renal cell carcinoma: Case report and literature review

Combination immunotherapy is a treatment strategy in patients with renal cell carcinoma that has proved to be effective in phase III randomized clinical trials. These studies do not include patients with end stage kidney disease on hemodialysis. We discuss this case about a patient with metachronous...

Descripción completa

Detalles Bibliográficos
Autores principales: Isaza, Alejandro Pineda, Franco, Alvaro Osorio, Quintero González, Lisceth Paola, Fajardo, Marcela Vallejo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529540/
https://www.ncbi.nlm.nih.gov/pubmed/36204593
http://dx.doi.org/10.1016/j.eucr.2022.102242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529540/
https://www.ncbi.nlm.nih.gov/pubmed/36204593
http://dx.doi.org/10.1016/j.eucr.2022.102242

Ejemplares similares